Hep C Virus - HGS to spin off gene research

HGS to spin off gene research
Baltimore Sun - Human Genome Sciences Inc. said yesterday that it would spin off its CoGenesys division as an independent company that will focus on the early development of the Rockville biotech's gene-based research and leave the commercialization of later-stage

XTL names CEO
Israel Business Arena - Ron Bentsur will replace chairman CEO Michael Weiss, who has served as acting CEO since February. Hadass Geyfman 11 Dec 05 17:36 Sources inform ''Globes'' that XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB ); LSE: XTL ; TASE: XTL ) has appointed Ron

Liver Cancer, Hepatitis C Connection Gets Clearer
Heart Info - WEDNESDAY, Dec. 7 (HealthDay News) -- Scientists have long noted a link between chronic hepatitis C infection and an increased risk for liver cancer , and a new study may help explain why. "What we've found is that one of the hepatitis C virus

FDA gives Fast Track status to Vertex s Hepatitis C treatment
Mass High Tech - The U.S. Food and Drug Administration has granted Fast Track designation to VX-950, an investigational oral hepatitis C virus (HCV) treatment being developed by Vertex Pharmaceuticals Inc. According to Vertex officials, the FDA granted the Fast Track